AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
NEW DRUGS IN BREAST-CANCER
Authors: MAURIAC L
Citation: L. Mauriac, NEW DRUGS IN BREAST-CANCER, European journal of cancer, 34, 1998, pp. 71-71
EORTC-10941 - FINAL RESULTS OF A PHASE-II STUDY OF LIAROZOLE FUMARATEIN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: KLIJN J HAMILTON A BEEX L MAURIAC L PARIDAENS R ROY JA AWADA A VANVRECKEM A PALMER P PICCART M
Citation: J. Klijn et al., EORTC-10941 - FINAL RESULTS OF A PHASE-II STUDY OF LIAROZOLE FUMARATEIN PATIENTS WITH METASTATIC BREAST-CANCER, European journal of cancer, 34, 1998, pp. 72-72
EORTC-10968 - PHASE-I STUDY OF CAELYX(TM) AT A 6-WEEK INTERVAL IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: HAMILTON A COLEMAN R MAURIAC L AWADA A PICCART M VANVRECKEM A BRUNING P
Citation: A. Hamilton et al., EORTC-10968 - PHASE-I STUDY OF CAELYX(TM) AT A 6-WEEK INTERVAL IN PATIENTS WITH METASTATIC BREAST-CANCER, European journal of cancer, 34, 1998, pp. 77-77
EORTC-IDBBC (INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER) - 7 YEARSOF ACTIVE EUROPEAN COLLABORATION
Authors: AWADA A CUFER T BEEX L COLEMAN R PARIDAENS R BRUNING P KLIJN J NOOIJ M MAURIAC L VANVRECKEM A BIGANZOLI L PICCART MJ
Citation: A. Awada et al., EORTC-IDBBC (INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER) - 7 YEARSOF ACTIVE EUROPEAN COLLABORATION, European journal of cancer, 34, 1998, pp. 86-86
LONG-TERM SURVIVAL OF PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR OPERABLE BREAST-TUMORS - RESULTS OF A RANDOMIZED TRIAL WITH A 10-YEAR-FOLLOW-UP
Authors: MAURIAC L MACGROGAN G DURAND M AVRIL A DILHUYDY JM
Citation: L. Mauriac et al., LONG-TERM SURVIVAL OF PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR OPERABLE BREAST-TUMORS - RESULTS OF A RANDOMIZED TRIAL WITH A 10-YEAR-FOLLOW-UP, European journal of cancer, 34, 1998, pp. 161-161
A NEW STANDARD TREATMENT FOR ADVANCED PREMENOPAUSAL BREAST-CANCER - AMETAANALYSIS OF THE COMBINED HORMONAL AGENT TRIALISTS GROUP (CHAT)
Authors: KLIJN JGM BLAMEY RW BOCCARDO F TOMINAGA T JONAT W KAUFMANN M BEEX L MAURIAC L HOCTINBOES G DUCHATEAU L SYLVESTER R
Citation: Jgm. Klijn et al., A NEW STANDARD TREATMENT FOR ADVANCED PREMENOPAUSAL BREAST-CANCER - AMETAANALYSIS OF THE COMBINED HORMONAL AGENT TRIALISTS GROUP (CHAT), European journal of cancer, 34, 1998, pp. 405-405
PREDICTIVE FACTORS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY BY IMMUNOHISTOCHEMISTRY (IHC)
Authors: MACGROGAN G MAURIAC L DURAND M BONICHON F FLOQUET A
Citation: G. Macgrogan et al., PREDICTIVE FACTORS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY BY IMMUNOHISTOCHEMISTRY (IHC), European journal of cancer, 34, 1998, pp. 514-514
AN EORTC-NCIC-SAKK NEOADJUVANT RANDOMIZED PHASE-III STUDY COMPARING CEF (5FU, EPIRUBICIN, CYCLOPHOSPHAMIDE) VS DOSE INTENSIFIED EC-CSF (FILGRASTIM) IN LOCALLY ADVANCED BREAST-CANCER (LABC) - UPDATED RESULTS INCLUDING QUALITY-OF-LIFE(G)
Authors: THERASSE P MAURIAC L WELNICKA M BRUNING P CUFER T TOMIAK E CURRAN D RAMIREZ A KOOPMANSCHAP M PICCART M
Citation: P. Therasse et al., AN EORTC-NCIC-SAKK NEOADJUVANT RANDOMIZED PHASE-III STUDY COMPARING CEF (5FU, EPIRUBICIN, CYCLOPHOSPHAMIDE) VS DOSE INTENSIFIED EC-CSF (FILGRASTIM) IN LOCALLY ADVANCED BREAST-CANCER (LABC) - UPDATED RESULTS INCLUDING QUALITY-OF-LIFE(G), Annals of oncology, 9, 1998, pp. 63-63
COMBINED TREATMENT WITH THE LHRH-AGONIST BUSERELIN (LHRH-A) AND TAMOXIFEN (TAM) VS SINGLE TREATMENT WITH EACH DRUG ALONE IN PREMENOPAUSAL METASTATIC BREAST-CANCER - FINAL RESULTS OF EORTC-STUDY-10881
Authors: KLIJN JGM BEEX L MAURIAC L VANZIJL J VEYRET C WILDIERS J JASSEM J BURGHOUTS J PICCART M MIGNOLET F DUCHATEAU L
Citation: Jgm. Klijn et al., COMBINED TREATMENT WITH THE LHRH-AGONIST BUSERELIN (LHRH-A) AND TAMOXIFEN (TAM) VS SINGLE TREATMENT WITH EACH DRUG ALONE IN PREMENOPAUSAL METASTATIC BREAST-CANCER - FINAL RESULTS OF EORTC-STUDY-10881, Annals of oncology, 9, 1998, pp. 540-540
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
IATROGENIC RISKS OF ENDOMETRIAL CARCINOMA AFTER TREATMENT FOR BREAST-CANCER IN A LARGE FRENCH CASE-CONTROL STUDY
Authors: MIGNOTTE H LASSET C BONADONA V LESUR A LUPORSI E RODIER JF CUTULI B LASRY S MAURIAC L GRANON C KERR C GIARD S HILL C DELAFONTAN B DEGISLAIN C DANJOU J FONDRINIER E LEFEUVRE C PARACHE RM CHAUVIN F
Citation: H. Mignotte et al., IATROGENIC RISKS OF ENDOMETRIAL CARCINOMA AFTER TREATMENT FOR BREAST-CANCER IN A LARGE FRENCH CASE-CONTROL STUDY, International journal of cancer, 76(3), 1998, pp. 325-330
SHORT-TERM VS LIFELONG ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER (EBC) - A RANDOMIZED TRIAL (TAM-01)
Authors: DELOZIER T SPIELMANN M MACELESECH J JANVIER M ASSELAIN B JULIEN JP WEBER B MAURIAC L PETIT JC KERBRAT P
Citation: T. Delozier et al., SHORT-TERM VS LIFELONG ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER (EBC) - A RANDOMIZED TRIAL (TAM-01), European journal of cancer, 33, 1997, pp. 343-343
ENDOMETRIAL CARCINOMA (EC) IN WOMEN WITH BREAST-CANCER (BC)
Authors: MIGNOTTE H LESUR A LUPORSI E RODIER JF CUTULI B LASRY S MAURIAC L GRANON C KERR C GIARD S HILL C DELAFONTAN B DEGISLAIN C DANJOU J FONDRINIER E LEFEUVRE C LASSET C BONADONA V CHAUVIN F
Citation: H. Mignotte et al., ENDOMETRIAL CARCINOMA (EC) IN WOMEN WITH BREAST-CANCER (BC), European journal of cancer, 33, 1997, pp. 925-925
CORTICOSTEROIDS SIGNIFICANTLY DELAY THE ONSET OF DOCETAXEL-INDUCED FLUID RETENTION - FINAL RESULTS OF A RANDOMIZED STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER
Authors: PICCART MJ KLIJN J PARIDAENS R NOOIJ M MAURIAC L COLEMAN R BONTENBAL M AWADA A SELLESLAGS J VANVRECKEM A VANGLABBEKE M
Citation: Mj. Piccart et al., CORTICOSTEROIDS SIGNIFICANTLY DELAY THE ONSET OF DOCETAXEL-INDUCED FLUID RETENTION - FINAL RESULTS OF A RANDOMIZED STUDY OF THE -ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER INVESTIGATIONAL DRUG BRANCH FOR BREAST-CANCER, Journal of clinical oncology, 15(9), 1997, pp. 3149-3155
IMMUNOHISTOCHEMICAL DETECTION OF PROGESTERONE RECEPTORS IN BREAST INVASIVE DUCTAL CARCINOMAS - A CORRELATIVE STUDY OF 942 CASES
Authors: MACGROGAN G SOUBEYRAN I DEMASCAREL I WAFFLART J BONICHON F DURAND M AVRIL A MAURIAC L TROJANI M COINDRE JM
Citation: G. Macgrogan et al., IMMUNOHISTOCHEMICAL DETECTION OF PROGESTERONE RECEPTORS IN BREAST INVASIVE DUCTAL CARCINOMAS - A CORRELATIVE STUDY OF 942 CASES, Applied immunohistochemistry, 4(4), 1996, pp. 219-227
A RANDOMIZED TRIAL COMPARING 2 DOSES OF THE NEW SELECTIVE AROMATASE INHIBITOR ANASTROZOLE (ARIMIDEX) WITH MEGESTROL-ACETATE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
Authors: JONAT W HOWELL A BLOMQVIST C EIERMANN W WINBLAD G TYRRELL C MAURIAC L ROCHE H LUNDGREN S HELLMUND R AZAB M
Citation: W. Jonat et al., A RANDOMIZED TRIAL COMPARING 2 DOSES OF THE NEW SELECTIVE AROMATASE INHIBITOR ANASTROZOLE (ARIMIDEX) WITH MEGESTROL-ACETATE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER, European journal of cancer, 32A(3), 1996, pp. 404-412
VINORELBINE 5-FU COMBINATION IN METASTATIC BREAST-CANCER CHEMOTHERAPY- A RETROSPECTIVE STUDY OF 63 CASES/
Authors: CANY L TOULOUSE C RAVAUD A DURAND M MAURIAC L
Citation: L. Cany et al., VINORELBINE 5-FU COMBINATION IN METASTATIC BREAST-CANCER CHEMOTHERAPY- A RETROSPECTIVE STUDY OF 63 CASES/, European journal of cancer, 32A(2), 1996, pp. 370-371
DELAY IN PROGRESSION OF BONE METASTASES IN BREAST-CANCER PATIENTS TREATED WITH INTRAVENOUS PAMIDRONATE - RESULTS FROM A MULTINATIONAL RANDOMIZED CONTROLLED TRIAL
Authors: CONTE PF LATREILLE J MAURIAC L CALABRESI F SANTOS R CAMPOS D BONNETERRE J FRANCINI G FORD JM
Citation: Pf. Conte et al., DELAY IN PROGRESSION OF BONE METASTASES IN BREAST-CANCER PATIENTS TREATED WITH INTRAVENOUS PAMIDRONATE - RESULTS FROM A MULTINATIONAL RANDOMIZED CONTROLLED TRIAL, Journal of clinical oncology, 14(9), 1996, pp. 2552-2559
BREAST-CANCER AND IN-VITRO FERTILIZATION - ABOUT 32 CASES
Authors: JOURDAIN O AVRIL A MAURIAC L QUENEL N BUSSIERES E ROUX D LAJUS C DALLAY D
Citation: O. Jourdain et al., BREAST-CANCER AND IN-VITRO FERTILIZATION - ABOUT 32 CASES, European journal of obstetrics, gynecology, and reproductive biology, 67(1), 1996, pp. 47-52
OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS
Authors: CLARKE M COLLINS R DAVIES C GODWIN J GRAY R PETO R ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M VANDEVELDE AO VANDONGEN JA VERMORKEN JB ARVELAKIS A GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP PEEK U OATES GD POWELL J BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL CIRRINCIONE C KORZUN A WEISS RB WOOD WC BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A HORGAN K HUGHES L STEWART HJ GORDON NH DAVIS HL LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ ABELOFF MD CARBONE PC GLICK J TORMEY DC ROSSBACH J SCANLON EF SCHURMAN S DESCHRYVER A YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLEFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVALLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S TASUTOMI T SONOO H YAMASHITA J OGAWA M HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S AHMANN D SCHAID DJ BUZDAR AU SMITH T HAKES T NORTON L WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM BROWN A FISHER B REDMOND C WOLMARK N JACKSON IM PALMER MK INGLE JN SUMAN VJ BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR NAKAMURA Y MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MYLES JD PATER JL PRITCHARD KI MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST A CROSSLEY E DURRANT K HARRIS A BEIGHTON A COLLINS R EVANS V GREAVES E HARWOOD C JAMES S LAU E MEAD G MULDAL A NAUGHTON A TOOTH A WHEATLEY K RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPEILMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CJ ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P HOST H BRYANT AJS EWING GH KRUSHENKOSLOSKI JL FORREST APM JACK W MCDONALD C MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC JAKESZ R GNANT M BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: M. Clarke et al., OVARIAN ABLATION IN EARLY BREAST-CANCER - OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 348(9036), 1996, pp. 1189-1196
EVALUATION OF P53, C-ERBB2, MIB1, PS2, GST-PI, ESTROGEN AND PROGESTERONE RECEPTORS, FOR PREDICTION OF RESPONSE TO PRIMARY CHEMOTHERAPY IN BREAST-CARCINOMA
Authors: GROGAN GM MAURIAC L BONICHON F DURAND M DEMASCAREL I TROJANI M COINDRE JM
Citation: Gm. Grogan et al., EVALUATION OF P53, C-ERBB2, MIB1, PS2, GST-PI, ESTROGEN AND PROGESTERONE RECEPTORS, FOR PREDICTION OF RESPONSE TO PRIMARY CHEMOTHERAPY IN BREAST-CARCINOMA, Laboratory investigation, 74(1), 1996, pp. 96-96
PRIMARY CHEMOTHERAPY IN BREAST INVASIVE-CARCINOMA - PREDICTIVE VALUE OF THE IMMUNOHISTOCHEMICAL DETECTION OF HORMONAL RECEPTORS, P53, C-ERBB-2, MIB1, PS2 AND GST-PI
Authors: MACGROGAN G MAURIAC L DURAND M BONICHON F TROJANI M DEMASCAREL I COINDRE JM
Citation: G. Macgrogan et al., PRIMARY CHEMOTHERAPY IN BREAST INVASIVE-CARCINOMA - PREDICTIVE VALUE OF THE IMMUNOHISTOCHEMICAL DETECTION OF HORMONAL RECEPTORS, P53, C-ERBB-2, MIB1, PS2 AND GST-PI, British Journal of Cancer, 74(9), 1996, pp. 1458-1465
PS2 PROTEIN - A MARKER IMPROVING PREDICTION OF RESPONSE TO NEOADJUVANT TAMOXIFEN IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
Authors: SOUBEYRAN I QUENEL N COINDRE JM BONICHON F DURAND M WAFFLART J MAURIAC L
Citation: I. Soubeyran et al., PS2 PROTEIN - A MARKER IMPROVING PREDICTION OF RESPONSE TO NEOADJUVANT TAMOXIFEN IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, British Journal of Cancer, 74(7), 1996, pp. 1120-1125
VARIATION OF HORMONAL RECEPTOR, PS2, C-ERBB-2 AND GST-PI CONTENTS IN BREAST CARCINOMAS UNDER TAMOXIFEN - A STUDY OF 74 CASES
Authors: SOUBEYRAN I QUENEL N MAURIAC L DURAND M BONICHON F COINDRE JM
Citation: I. Soubeyran et al., VARIATION OF HORMONAL RECEPTOR, PS2, C-ERBB-2 AND GST-PI CONTENTS IN BREAST CARCINOMAS UNDER TAMOXIFEN - A STUDY OF 74 CASES, British Journal of Cancer, 73(6), 1996, pp. 735-743
IMMUNOHISTOCHEMICAL ANALYSIS OF ESTROGEN-RECEPTORS IN 938 BREAST CARCINOMAS - CONCORDANCE WITH BIOCHEMICAL ASSAY AND PROGNOSTIC-SIGNIFICANCE
Authors: DEMASCAREL I SOUBEYRAN I MACGROGAN G WAFFLART J BONICHON F DURAND M AVRIL A MAURIAC L TROJANI M COINDRE JM
Citation: I. Demascarel et al., IMMUNOHISTOCHEMICAL ANALYSIS OF ESTROGEN-RECEPTORS IN 938 BREAST CARCINOMAS - CONCORDANCE WITH BIOCHEMICAL ASSAY AND PROGNOSTIC-SIGNIFICANCE, Applied immunohistochemistry, 3(4), 1995, pp. 222-231
Risultati: 1-25 | 26-30